Activation of Conjunctiva-Associated Lymphoid Tissue in Diabetic Patients

Ocul Immunol Inflamm. 2023 Feb;31(2):312-319. doi: 10.1080/09273948.2022.2027462. Epub 2022 Feb 3.

Abstract

Purpose: To evaluate changes in conjunctiva-associated lymphoid tissues (CALTs) in patients with type 2 diabetic mellitus (T2DM).

Methods: Thirty-two patients with T2DM and 32 healthy volunteers underwent comprehensive examinations. In vivo confocal microscopy and Image J were used to observe and evaluate the patients' CALT-related parameters. Conjunctival impression cytology (CIC) samples of the tarsal conjunctiva were collected from the patients, and CD4+ and CD8+ cells were evaluated by immunofluorescence staining.

Results: The diabetes group showed higher diffuse lymphocyte density(p < .001), follicular density(p < .001) and parafollicular lymphocyte density(p < .001). The percentages of CD4+ cells (p < .001) and CD8+ cells (p < .001) in the diabetes group were higher than those in the control group. CALT-related parameters of the diabetic patients with diabetic retinopathy showed higher degrees of activation than those of the diabetic patients without diabetic retinopathy.

Conclusions: CALT activation is observed in patients with T2DM, and the activation is more obvious in patients with diabetic retinopathy.

Trial registration number: Retrospectively registered, ChiCTR2100046030.

Keywords: Conjunctiva-associated lymphoid tissues; conjunctival impression cytology; diabetic mellitus; in vivo confocal microscopy.

MeSH terms

  • CD4-Positive T-Lymphocytes
  • Conjunctiva
  • Diabetes Mellitus, Type 2* / complications
  • Diabetic Retinopathy*
  • Humans
  • Lymphoid Tissue